Rather than banning the sale of syringes without a doctor's prescription to prevent drug abuse, it will be better if the government hastens the switch over to auto-disable syringes, said a senior medical devices industry official.
He was referring to the recent ban on sale of syringes without doctor's prescription in some districts in Punjab as a measure to fight drugs.
"While the law exists in the US of syringe sale limited to prescription, this is not the case in India and the intent of solving a problem may be noble but the management tool being used is questionable," Rajiv Nath, Forum Coordinator at Association of Indian Medical Device Industry (AIMED) told IANS.
He is also the Joint Managing Director of Hindustan Syringe and Medical Devices Ltd.
According to Nath, the ban on sale of syringes without a doctor prescription will amplify the problem of syringe reuse by drug addicts and accelerate the spread of Hepatitis C in Punjab.
He said Punjab has the highest Hepatitis B and C spreading from drug addicts to other patients in the already challenged healthcare infrastructure.
"It would be more prudent to accelerate a switch to auto-disable syringes in private sector in Punjab and have a state policy as was done by Government of Andhra Pradesh to prevent reuse with the help of state drug controller to address this magnifying problem in Punjab," Nath said.
--IANS
vj/mag/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
